Acnesone 7.5% Gel

Acnesone 7.5% Gel Uses, Dosage, Side Effects, Food Interaction and all others data.

Acnesone 7.5% Gel inhibits folic acid synthesis by preventing normal bacterial utilization of PABA (Para-aminobenzoic acid).

Acnesone 7.5% Gel is a sulfone with anti-inflammatory immunosuppressive properties as well as antibacterial and antibiotic properties. Acnesone 7.5% Gel is the principal drug in a multidrug regimen recommended by the World Health Organization for the treatment of leprosy. As an anti-infective agent, it is also used for treating malaria and, recently, for Pneumocystic carinii pneumonia in AIDS patients. Acnesone 7.5% Gel is absorbed rapidly and nearly completely from the gastrointestinal tract. Acnesone 7.5% Gel is distributed throughout total body water and is present in all tissues. However, it tends to be retained in skin and muscle and especially in the liver and kidney: traces of the drug are present in these organs up to 3 weeks after therapy cessation.

Acnesone 7.5% Gel
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Acnesone 7.5% Gel
Availability	Prescription only
Generic	Dapsone
Dapsone Other Names	DADPS, Dapsona, Dapsone, Dapsonum, Diaphenylsulfone
Related Drugs	prednisone, clindamycin, dexamethasone, sulfamethoxazole / trimethoprim, Bactrim, Decadron, rifampin, Bactrim DS, Deltasone, Cleocin
Weight	7.5%
Type	Gel
Formula	C₁₂H₁₂N₂O₂S
Weight	Average: 248.301 Monoisotopic: 248.061948328
Protein binding	70 to 90%
Groups	Approved, Investigational
Therapeutic Class	Anti-Leprotic drugs
Manufacturer	Incepta Pharmaceuticals Ltd.
Available Country	Bangladesh
Last Updated:	September 24, 2024 at 5:38 am

Uses

Acnesone 7.5% Gel is used for Primary and secondary prophylaxis of Pneumocystis (carinii) jirovecii pneumonia, Multibacillary leprosy, Paucibacillary leprosy, Dermatitis herpetiformis, Acne

Acnesone 7.5% Gel is also used to associated treatment for these conditions: Acne Vulgaris, Bullous Systemic Lupus Erythematosus, Bullous dermatitis herpetiformis, Hansen's Disease, Pemphigus Vulgaris (PV), Relapsing Polychondritis, Mild Pneumocystis pneumonia, Mild Toxoplasma gondii encephalitis, Moderate Pneumocystis pneumonia, Moderate Toxoplasma gondii encephalitis, Refractory Idiopathic thrombocytopenic purpura

How Acnesone 7.5% Gel works

Acnesone 7.5% Gel acts against bacteria and protozoa in the same way as sulphonamides, that is by inhibiting the synthesis of dihydrofolic acid through competition with para-amino-benzoate for the active site of dihydropteroate synthetase. The anti-inflammatory action of the drug is unrelated to its antibacterial action and is still not fully understood.

Dosage

Acnesone 7.5% Gel dosage

Primary and secondary prophylaxis of Pneumocystis (carinii) jirovecii pneumonia:

Adult: 50 mg daily, with pyrimethamine 50 mg once wkly. Alternatively, 100 mg with pyrimethamine 50 mg twice wkly.
Child: 1 mth-18 yr: 2 mg/kg daily (max: 100 mg daily) or 4 mg/kg wkly (max: 200 mg wkly).

Multibacillary leprosy:

Adult: 100 mg daily with clofazimine 50 mg daily, together with rifampicin 600 mg and clofazimine 300 mg once a mth for 12 mth.
Child: and child 10-14 yr old: daily doses of dapsone 50 mg, or 1 to 2 mg/kg if their body-weight is low

Paucibacillary leprosy:

Adult: 100 mg daily with 600 mg rifampicin once a mth, both given for 6 mth.
Child: Reduce dose as for multibacillary leprosy.

Dermatitis herpetiformis:

Adult: Initially, 50 mg daily increased gradually to 300 mg daily if required.

Side Effects

Anaemia, peripheral neuropathy, haemolysis and methaemoglobinaemia (dose-related), nephrotic syndrome, psychological changes, hepatitis. Others: Nausea, vomiting, anorexia, headache, maculopapular rash, toxic epidermal necrolysis, Stevens-Johnson syndrome. Topical: Dryness, redness, oiliness and peeling at application site.

Toxicity

Overdosage might be expected to produce nasal congestion, syncope, or hallucinations. Measures to support blood pressure should be taken if necessary.

Precaution

G6PD deficiency, methaemoglobin or Hb M. Perform regular blood counts and monitor liver function regularly. Pregnancy and lactation.

Interaction

Decreased serum conc of dapsone when used with rifampicin. Increased plasma conc with probenecid, trimethoprim. Antagonize clofazimine.

Food Interaction

Take with or without food. The absorption is unaffected by food.

Acnesone 7.5% Gel Drug Interaction

Moderate: hydroxychloroquine, hydroxychloroquineUnknown: mycophenolate mofetil, mycophenolate mofetil, duloxetine, duloxetine, furosemide, furosemide, pregabalin, pregabalin, cyanocobalamin, cyanocobalamin, ascorbic acid, ascorbic acid, cholecalciferol, cholecalciferol, ondansetron, ondansetron, cetirizine, cetirizine

Acnesone 7.5% Gel Disease Interaction

Major: bone marrow suppressionModerate: liver disease

Elimination Route

Bioavailability is 70 to 80% following oral administration.

Half Life

28 hours (range 10-50 hours)

Elimination Route

Renal

Pregnancy & Breastfeeding use

Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.

Contraindication

Hypersensitivity. Severe anaemia, porphyria.

Acute Overdose

Symptoms: nausea, vomiting, hyperexcitability (within a few min to up to 24 hr later), methemoglobin-induced depression, haemolysis (7-14 days after ingestion), seizures and severe cyanosis.

Treatment: activated charcoal (20g four times daily) and haemolysis may enhance elimination of dapsone and its monoacetyl derivative. For patients without G6PD deficiency, methemoglobinemia may be treated with methylene blue 1-2 mg/kg given by slow IV injection (repeated if methemoglobin reaccumulates) or in less severe cases, 3-5 mg/kg every 4-6 hr orally.